Home » Videos » News18 Shorts » Three Studies On Arthritis Drug Tocilizumab Gives Mixed Results In Treating COVID-19

Three Studies On Arthritis Drug Tocilizumab Gives Mixed Results In Treating COVID-19

Oct 21, 2020 06:22 PM IST iVideos iVideos
Share

A trio of new studies published in JAMA Internal Medicine on the efficacy of Tocilizumab against COVID-19 showed inconsistent results. Tocilizumab, an arthritis drug, has been used by doctors since the start of the pandemic with the hope of tamping down a "cytokine storm".

Loading